The Canadian sequencing technology market is ready for substantial expansion through 2032, according to a latest report. Driving this favorable climate are several factors, including a rising prevalence of genetic disorders, an widening attention on precision treatment, and continued improvements in NGS technology. Moreover, the public commitment t